4.5 Article

Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the Catch a Break 1i [type C] FLS

Journal

OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 6, Pages 1965-1977

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-017-3986-3

Keywords

Cost-effectiveness analysis; Fracture liaison services; Fragility fracture; Guidelines; Osteoporosis treatment; Quality improvement

Funding

  1. Alberta Innovates (STOP-PRIHS grant)
  2. Faculty of Medicine and Dentistry at the University of Alberta
  3. Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta
  4. Canadian Institutes of Health Research
  5. Alberta Innovates
  6. Alberta Innovates [201400391] Funding Source: researchfish

Ask authors/readers for more resources

Fracture liaison services (FLS) are advocated to improve osteoporosis treatment after fragility fracture, but there are few economic analyses of different models. A population-based 1i [=type C] FLS for non-hip fractures was implemented and it costs $44 per patient and it was very cost-effective ($9200 per QALY gained). Small operational changes would convert it from cost-effective to cost-saving. After fragility fracture, < 20% of patients receive osteoporosis treatment. FLS are recommended to address this deficit but there are very few economic analyses of different FLS models. Therefore, we conducted an economic analysis of a 1i (=type C) FLS called Catch a Break (CaB). CaB is a population-based FLS in Alberta, Canada, that case-finds older outpatients with non-traumatic upper extremity, spine, pelvis, or other non-hip fractures and provides telephonic outreach and printed educational materials to patients and their physicians. Cost-effectiveness was assessed using Markov decision-analytic models. Costs were expressed in 2014 Canadian dollars and effectiveness based on model simulations of recurrent fractures and quality-adjusted life years (QALYs). Perspective was healthcare payer; horizon was lifetime; and costs and benefits were discounted 3%. Over 1 year, CaB enrolled 7323 outpatients (mean age 67 years, 75% female, 69% upper extremity) at average cost of $44 per patient. Compared with usual care, CaB increased rates of bisphosphonate treatment by 4.3 to 17.5% (p < 0.001). Over their lifetime, for every 10,000 patients enrolled in CaB, 4 hip fractures (14 fractures total) would be avoided and 12 QALYs gained. Compared with usual care, incremental cost-effectiveness of CaB was estimated at $9200 per QALY. CaB was cost-effective in 85% of 10,000 probabilistic simulations. Sensitivity analyses showed if other fractures were excluded and intervention costs reduced 25% that CaB would become cost-saving. A relatively inexpensive population-based 1i (=type C) FLS was implemented in Alberta and it was very cost-effective. If CaB excluded other fractures and decreased intervention costs by 25%, it would be cost-saving, as would any FLS that was more effective and less expensive.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available